Ruffer Portfolio holdings
Ruffer is an independent investment manager owned and run by its partners, with a single global strategy aimed at not losing money over any rolling 12-month period. Jonathan Ruffer, who began as a stockbroker and then became a barrister, started it in 1994 with Robert Shirley, 14th Earl Ferrers, and Jane Tufnell, and it became Ruffer LLP in 2004. The firm starts by weighing the risks it sees in markets and picking assets that should protect the portfolio if they come true, then takes on growth mainly through global stocks. It runs a stock-market-listed investment company, and its clients include pension plans, charities and family offices.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$210M |
| 2 |
Cigna
CI
|
+$98.8M |
| 3 |
Walt Disney
DIS
|
+$95.6M |
| 4 |
McKesson
MCK
|
+$66.2M |
| 5 |
Barrick Mining
B
|
+$53.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
|
+$32.3M |
| 2 |
GG
Goldcorp Inc
GG
|
+$30.1M |
| 3 |
Eldorado Gold
EGO
|
+$25.6M |
| 4 |
AUY
Yamana Gold, Inc.
AUY
|
+$25.1M |
| 5 |
ChampionX
CHX
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 42.04% |
| 2 | Healthcare | 17.68% |
| 3 | Communication Services | 15.57% |
| 4 | Energy | 12.77% |
| 5 | Consumer Discretionary | 7.5% |
Similar funds
Ruffer's Q1 2019 Portfolio in Review
As of Q1 2019, Ruffer held 106 positions worth $3.9B, up 22% from $3.19B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Ruffer deployed $451M of net new capital in Q1 2019, opening 10 new positions and adding to 18 existing holdings. Its largest new stake was Celgene Corp: 2,402,474 shares worth $227M.
By sector, the portfolio is most concentrated in Materials at 42% of assets, down from 48% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Delphi Technologies PLC Ordinary Shares, an estimated $32.3M trimmed.
- Ruffer's largest Q1 2019 buy was Celgene Corp: 2,402,474 shares worth $227M.
- Ruffer added most to Cigna in Q1 2019, an estimated $98.8M increase.
- Ruffer's biggest Q1 2019 reduction was Delphi Technologies PLC Ordinary Shares, cutting an estimated $32.3M.
- Ruffer fully exited Ensco Rowan plc in Q1 2019, selling an estimated $24.9M.
- Ruffer's ten largest holdings make up 71% of its $3.9B portfolio in Q1 2019.
- Ruffer opened 10 new positions and closed 16 in Q1 2019.
- Ruffer's portfolio value rose 22% quarter-over-quarter to $3.9B.
Based on Ruffer's 13F filing for Q1 2019, filed 10 May 2019.